2^nd Glycobiology World Congress August 29-31,2016 Atlanta, USA

Neil Price has a Ph.D. from the University of London, and has postdoctoral experience at the Univ. of Geneva in Switzerland, Paul-Sabatier University in Toulouse, and the Complex Carbohydrate Research Center in Athens, GA. He held a faculty position the U. of Rochester, NY before moving to the NCAUR, Peoria.

His research includes carbohydrate chemistry and biochemistry, mass spectrometry, and microbial metabolism. He currently serves on the ARS National Chemical Patent committee, and has over 90 peer-reviewed research publications.

Dr. Menter received his Ph.D. degree in Chemistry from the George Washington University in 1969. He completed a postdoctoral fellowship with Prof. Dr. Theodor Foerster at the Institut fuer physikalische Chemie der Universtiaet Stuttgart, Germany. Subsequently, he was at the University of Alabama, Birmingham, and the VA Medical Center (Atlanta) He currently serves as Research Professor of Biochemistry at Morehouse School of Medicine. Dr. Menter is recognized internationally for his work in the areas of collagen photochemistry and melanin photobiology as pertaining to redox reactivity.

His research interest includes in the areas of collagen photochemistry and melanin photobiology as pertaining to redox reactivity.

Maria Longas completed her PhD at New York University in 1978, and did her postdoctoral training at Columbia University School of Medicine with Dr. Karl Mayer. She has an MA in Organic Chemistry from New York University (1973) and a BA in Chemistry from Hunter College (1971). She is a full Professor of Chemistry at Purdue University Calumet in Hammond, IN. She has more than 24 papers published in reputable journals, and served as a reviewer for several journals.

Her research interest includes arthritis, tuberculosis and autoimmune disorders.

Myron R Szewczuk has completed his PhD in 1974 from University of Windsor in Biology and Immunochemistry and Postdoctoral studies from Cornell University Medical College, New York City, USA in Cellular Immunology with Dr Greg Siskind (1975-1978). He is presently a Full Professor of Immunology and Associate Professor of Medicine, Queen’s University, Canada. He has published more than 100 papers in reputed journals and has been serving as an editorial Board Member of repute.

His research interest includes the alternate therapeutic treatment of cancer and the role of glycosylation in the activation of neurotrophin Trk, EGFR, insulin and TOLL-like receptors.

Professor Marzabadi completed her PhD at the University of Missouri – St. Louis and carried out postdoctoral studies at Hunter College- CUNY. She has been at Seton Hall University for the past 15 years and has been a Visiting Professor at Harvard University Medical School and a Visiting Researcher at Memorial Sloan Kettering Cancer Center. She has published numerous papers in the carbohydrate literature and currently serves as a Member at Large for the ACS Division of Carbohydrate Chemistry.

Her research interest includes the synthesis and biological evaluation of new carbohydrate structures with the capacity to act as immunomodulators.

Dr. Desai is the Director of Institute for Structural Biology, Drug Discovery and Development at Virginia Commonwealth University. He earned his PhD from Indian Institute of Technology, Bombay and did postdoctoral studies at Iowa, MIT and Illinois. He was awarded the Established Investigator Award by the American Heart Association and the Distinguished Scholarship Award by Virginia Commonwealth University.

His research interest includes Structural Biology, Drug Discovery and Development.

Dev Arya earned his B.Sc. (chemistry honors program) from St. Stephen's College, Delhi; and Ph.D. (Bioorganic Chemistry) from Northeastern University, Boston. After spending his postdoctoral years in the labs of Prof. T. C. Bruice (UC Santa Barbara), he joined the faculty at Clemson University. Dr. Arya is a recipient of a National Science Foundation CAREER Award (2002) and the ACS Horace S. Isbell Award of the Division of Carbohydrate Chemistry (2007). He has served as the Program Chair (2004-2008), Chair-Elect (2009-2010) and Chair (2010-2011) of the ACS Division of Carbohydrate Chemistry.

His research interest includes the design, and discovery of new motifs for the molecular recognition of biological macromolecules.

JDM has completed his PhD at Carlsberg Laboratory, before he moved to Danisco, now Danisco/Dupont, where he worked 20 years as scientist and Research Manager and finally Director of Research in Danisco Biotechnology. He moved to the Technical University in 2008 with a Danisco grant to establish a group working on enzymes, hydrocolloids and prebiotic oligosaccharides. He has published 138 publications and 25 Patents.

His research interest includes functional glycans and human milk oligosaccharides.

Rachel Chen received her PhD from California Institute of Technology in 1994 and subsequently worked as a research scientist in Bristol-Myers Squibb. She began her independent academic career in Virginia Commonwealth University and continues at Georgia Institute of Technology. Her research interfaces biology, chemistry, and engineering with major focuses on applying molecular engineering tools in the synthesis of molecules that are not attainable with conventional means. She has published ~80 peer-reviewed papers and has been serving as an associate editor for Microbial Cell Factories and on editorial boards of AIMS Bioengineering and AIMS Microbiology.

Her research interfaces biology, chemistry, and engineering with major focuses on applying molecular engineering tools in the synthesis of molecules that are not attainable with conventional means.

Cheorl-Ho Kim has completed his Ph.D at the age of 28 years from The University of Tokyo and was positioned as a senior scientist from Korea Research Institute of Bioscience and Biotechnology. He is a professor of Molecular Glycobiology, SungKyunKwan University, Korea, leading organization of Korea, which is cooperated with the SamSung Group. He has published more than 341 papers in reputed journals and serving as an editorial board member, executive editor and editor-in chief of the international journals. His work was contributed to the mechanisms of glycan-mediated Hepatis B viral oncogenesis and invasion, sialoglycan-mediated leukemic differentiation and vascular biology. He is being serves as an Editor-in-Chief of Journal of Glycobiology, Editor-in-Chief of Journal of Microbial and Biochemical Technology, Executive Editor of Journal of Glycomics and Lipidomics, Editor of eCAM, Editor of The Peer Journal and Editor of Current Pharmaceutical Biotechnology.

His research work was contributed to the mechanisms of glycan-mediated Hepatis B viral oncogenesis and invasion, sialoglycan-mediated leukemic differentiation and vascular biology.

Tongzhong Ju received his M.D. degree from the Qingdao Medical College
in1986 and his Ph.D. in Biochemistry from Fudan University Shanghai
Medical School (former Shanghai Medical University, China) in 1994. He
completed his post-doctoral training in Biochemistry/Glycobiology in 1999, worked as a Research Associate (1999-2002) and Research Assistant
Professor (2002-2006) at the University of Oklahoma Health Sciences
Center (OUHSC). He has published more than 50 papers in many different reputable journals.

His research interest mainly includes the study of glycan biomarkers for human diseases.

Amélia Pilar Rauter has made her Habilitation at Faculty of Sciences, University of Lisbon (FCUL, 2002) and completed her Ph.D. at Technische Universitaet Graz, Austria (1982). She is the Head of the Carbohydrate Chemistry Group - Center of Chemistry and Biochemistry (FCUL), and has been serving as Editor (RSC Carbohydrate Chemistry book series), Associated Editor (Mediterranean Journal of Chemistry), and member of journals advisory board in Organic/Carbohydrate Chemistry. She is Secretary of the European Carbohydrate Organisation and Secretary of the IUPAC Division on Organic and Biomolecular Chemistry, has published more than 130 papers and book chapters, and authored 12 patents.

Antimicrobial drugs and glycolipids.

Dr. Kubick is head of the department “Cell-free Bioproduction” at the Fraunhofer IZI-BB. His laboratory exploits cell-free protein synthesis as a versatile tool for membrane protein and glycoprotein synthesis, as well as chip-based protein synthesis and translational regulation. In collaboration with Qiagen GmbH he developed novel eukaryotic in vitro translation systems. Dr. Kubick is also a lecturer at the Free University of Berlin and the University of Potsdam. He is an affiliate of the Technical University of Berlin and Lecturer at the University of Applied Sciences, Berlin, Germany.

His research interest includes glycoprotein synthesis, as well as chip-based protein synthesis and translational regulation.

Ulrich Zähringer obtained his PhD degree in 1979 with H Grisebach, Biochemistry of Plants, Freiburg University, Germany. In 1981 he moved with Prof. Ernst T Rietschel, Director at the Research Center Borstel, where he obtained a tenure position as head of the Division of Immunochemistry. He made three postdoctoral trainings: i) 1980-1981 in O Lüderitz’s Lab at the Max-Planck-Institute for Immunobiology, Freiburg; ii) 1983-1984 at T Shiba’s and S Kusumoto’s Lab, University of Osaka, Faculty of Sciences, Osaka, Japan, and iii) during 2004-2005 with S Grzesiek, NMR Structural Biology at the Biozentrum in Basel, Switzerland. In 1996 he finished his habilitation and promoted in 2002 as extraordinary Professor at the University of Lübeck till his retirement in 2012. He published more than 250 papers in peer-reviews journals and 55 reviews.

His major interests are the analysis of structure-function relationship of pro-inflammatory bacterial compounds, such as lipopolysaccharide (LPS), oligosaccharides, lipopeptides, lipoteichoic acids (LTA) and peptidoglycan (PGN).

Prof. Joon Kim has completed his BS and MS in Microbiology from Seoul National University, PhD in Biochemistry from the University of California at Berkeley and postdoctoral study from Harvard Medical School. He is a Professor in the Division of Life Sciences, and the Director of Radiation Safety and Management Center, Korea University, Seoul, Korea. He has published more than 150 papers in reputed journals

Cancer and Cancer Marker.

Nada Al-Hasawi graduated from the Faculty of Science at Kuwait University in 1995 with a degree of Biochemistry and subsequently an M. Sc. In 1999. She worked first as Scientific Assistant, then as Department Technician and then for 5 years as a Teaching Assistant in the Faculty of Pharmacy at Kuwait University before taking up a scholarship to study for a Ph. D. at the Institute of Cancer Therapeutic at Bradford University, England. Following its completiion in 2008 she was appointed to her present position as Assistant Professor in Departmenmt of Pharmaceutical Chemistry, Faculty of Pharmacy at Kuwait University. Dr Al Hasawi’s current interests focus on the role of polysialic acid in metastatic cancers.

Dr Al Hasawi’s current interests focus on the role of polysialic acid in metastatic cancers.

Dr. Ming Zhang received the Ph.D. degree (Summa Cum Laude) from University of Gottingen, Germany. She has over a decade experience in infectious diseases, in particular targeting vaccine designs for HIV and influenza viruses. She is an Assistant Professor of Epidemiology at University of Georgia, USA, and leads an interdisciplinary research group towards understanding pathogen diversity and mechanisms for vaccine design purposes. She is also keen in educating the next generation of critical thinkers and innovators in infectious diseases.

Her research interests includes N-linked glycosylation and infectious diseases.